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Abstract: The rise of antibiotic-resistant Klebsiella pneumoniae, a leading nosocomial pathogen, prompts
the need for alternative therapies. We have identified and characterized a novel depolymerase enzyme
encoded by Klebsiella phage KP36 (depoKP36), from the Siphoviridae family. To gain insights into the
catalytic and structural features of depoKP36, we have recombinantly produced this protein of 93.4 kDa
and showed that it is able to hydrolyze a crude exopolysaccharide of a K. pneumoniae host. Using
in vitro and in vivo assays, we found that depoKP36 was also effective against a native capsule of
clinical K. pneumoniae strains, representing the K63 type, and significantly inhibited Klebsiella-induced
mortality of Galleria mellonella larvae in a time-dependent manner. DepoKP36 did not affect the
antibiotic susceptibility of Klebsiella strains. The activity of this enzyme was retained in a broad
range of pH values (4.0–7.0) and temperatures (up to 45 ◦C). Consistently, the circular dichroism
(CD) spectroscopy revealed a highly stability with melting transition temperature (Tm) = 65 ◦C.
In contrast to other phage tailspike proteins, this enzyme was susceptible to sodium dodecyl sulfate
(SDS) denaturation and proteolytic cleavage. The structural studies in solution showed a trimeric
arrangement with a high β-sheet content. Our findings identify depoKP36 as a suitable candidate for
the development of new treatments for K. pneumoniae infections.
Keywords: bacteriophage; Klebsiella sp.; capsule; polysaccharide depolymerase
1. Introduction
Klebsiella pneumoniae ranks among the eight most common etiological factors of nosocomial
infections, including pneumonia and urinary tract infections, accounting for up to 8% of all cases [1].
Furthermore, it is the second cause (after Escherichia coli) of both hospital- and community-acquired
gram-negative bacteremia [1]. It has been reported that the number of Klebsiella strains harbouring
extended spectrum beta-lactamases (ESBLs) and carbapenemases (KPC, MBL, OXA-48), which confer
multidrug resistance, has significantly increased in recent years [2–5]. In Europe, the prevalence of
ESBL- and KPC-producing Klebsiella among invasive isolates has reached 21% and 8.3%, respectively.
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One of the most important virulence factors of K. pneumoniae is the polysaccharide, that surrounds
the cell and may be organized into a distinct structure termed a capsule (capsular polysaccharide, CPS),
or it can be released as an exopolysaccharide (EPS). CPS is a complex of acidic polysaccharide structure
composed of repeating subunits of three to six sugars [1], with numerous configurations leading to
identify at least 78 distinct CPS types [6–8]. CPS is critical for the resistance of K. pneumoniae to host
defense mechanisms, suppression of early inflammatory response, adherence, and biofilm formation [9].
It also impedes or blocks the penetration of certain antibiotics into bacterial cells [10]. Additionally, it
can provide a physical barrier to prevent the harmful effects of the environmental conditions, and to
limit or preclude phage access [11]. The co-evolution of phages and their host bacteria has resulted
in the formation of phage-encoded enzymes that depolymerize the highly specific polysaccharide
structures, in order to gain access to the outer membrane and subsequently inject DNA into the
bacterium [12,13]. The depolymerase enzymes associated with capsular-targeting phage particles
reduce the viscosity of CPS and strip it from the surface of encapsulated bacteria [12]. The majority of
Klebsiella acting enzymes randomly attack glycosidic linkages of CPS to release repeating units of the
polymer [14–16]. The enzymatic loss of a capsule or alteration of its composition, makes bacteria devoid
of an important shield and, therefore, more susceptible. As a result, capsular-targeting phages or their
depolymerases in combination with other therapeutic agents could be exploited for the eradication of
virulent pathogens.
Multiple applications of depolymerases have been proposed, including determination of Klebsiella
capsular types for clinical strains [8,17], production of oligosaccharides from polysaccharides [18,19],
or as alternative therapeutic agents to treat Klebsiella infections [17,20]. The latter application is of
particular importance, as this opportunistic pathogen is a growing concern for public health.
In our previous study, the phage KP36 (vB_KpnS_KP36), whose genome encompasses 49,797 base
pairs (bp) encoding 80 gene products, was characterized [21]. Transmission electron microscopy and
genome sequence analyses revealed that this phage belongs to the family Siphoviridae, and is currently
classified as a member of the “KP36likevirus” genus within subfamily Tunavirinae [22].
In the present work, we proved that the K. pneumoniae phage KP36 expresses an enzyme
able to degrade the bacterial capsule and that this activity is conditioned by a tailspike protein
with depolymerase activity. We also recombinantly produced this protein and characterized its
biochemical properties, structural features in solution, as well as its activity in vitro and in vivo on
Galleria mellonella model.
2. Materials and Methods
2.1. Phage, Bacterial Strains, and Culture Conditions
We originally isolated Klebsiella phage KP36 from biologically-treated sewage in Poland using
the K. pneumoniae clinical isolate 486 as the host strain [21]. This phage and bacterial strain have been
deposited in the Polish Collection of Microorganisms (Institute of Immunology and Experimental
Therapy, Polish Academy of Sciences, Wroclaw, Poland) under accession numbers F/00068 and
B/F/00068, respectively. They are publicly available from the authors upon request. The phage
genome sequence has been deposited in GenBank/EMBL under the accession NC_029099. Besides the
host strain, ESBL-producing clinical isolates were also analyzed using the spot method. These included
the host strain, nine other strains (11, 27, 39, 74, 77, 271, 767, 1636, 7809131) belonging to the Institute of
Genetics and Microbiology Bacterial Collection (Wroclaw, Poland), and K. pneumoniae 700603 obtained
from the American Type Culture Collection (Microbiologics, St. Cloud, MN, USA). The evaluation
of capsular type was performed using wzi sequencing according to the method of Brisse et al. [23].
Klebsiella strains were routinely grown in Trypticase Soy Broth or Agar (TSB or TSA, BioMérieux,
Marcy-l’Étoile, France) at 37 ◦C. E. coli strains (Invitrogen, Thermo Fisher Scientific, Waltham, MA,
USA) were used: top 10 F′ for plasmid propagation and BL21(DE3) for recombinant protein expression.
These strains were cultivated in Lysogeny Broth (LB, BioCorp, Warszawa, Poland) at 37 ◦C.
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2.2. Cloning, Expression, and Purification
Bacteriophage KP36 genomic DNA was extracted and purified as previously described [21].
The gp50 open reading frame (ORF; NCBI acc. No. YP_009226010.1) encoding the depolymerase
enzyme encoded by Klebsiella phage KP36 (depoKP36) was amplified by PCR using the specific primer
pair: 5′-ATGGGGATTAAAACGCGGGTTACATTC-3′ and 5′-TTTCAGATCCTTAATGCATAGTTATATT
C-3′ (Genomed, Warszawa, Poland) and Pfu DNA polymerase (Fermentas, Thermo Fisher Scientific).
The 2649 bp PCR amplification product was subsequently cloned into the pEXP5-CT/TOPO®
expression vector (Invitrogen, Carlsbad, CA, USA) with a C-terminal His6 tag. Clone integrity was
verified by DNA sequencing (Genomed). Following transformation of the correct construct into E. coli
BL21(DE3) strain, plasmid-bearing cells were grown in 750 mL of LB supplemented with 100 µg/mL
ampicillin at 37 ◦C with vigorous agitation to an optical density (OD600nm) of ~0.6. Recombinant protein
expression was induced at 20 ◦C for 18 h by the addition of isopropyl-β-D-thiogalactopyranoside
(IPTG) to a final concentration of 0.1 mM. Next, the culture was harvested by centrifugation (5000× g,
20 min, 4 ◦C) and the pellet was resuspended in lysis buffer (300 mM NaCl, 20 mM Tris-HCl, 10 mM
imidazole, 5% (v/v) glycerol, pH 7.8) containing complete protease inhibitor cocktail (Roche Diagnostics,
Mannheim, Germany). After sonication, the whole-cell lysate was then centrifuged (12,500× g, 30 min,
4 ◦C) and the soluble fraction was filtered through a 0.22 µm filter (Millipore, Darmstadt, Germany).
The His-tagged protein purification was performed with a Ni-NTA His·Bind® Resins (Novagen, EMD
Millipore, Darmstadt, Germany) in gravity columns or Bio-Scale Mini Profinity IMAC cartridges
(Bio-Rad, Hercules, CA, USA) in combination with FPLC-system (Bio-Rad). After column equilibration
with the washing buffer (300 mM NaCl, 20 mM Tris-HCl, 10 mM imidazole, 5% (v/v) glycerol, pH 7.8),
the lysate was loaded and washed with 15 volumes of washing buffer. The protein was eluted (300 mM
NaCl, 20 mM Tris-HCl, 150 mM imidazole, 5% (v/v) glycerol, pH 7.8) and dialyzed overnight at 4 ◦C
against a 1000-fold volume of phosphate-buffered saline (PBS) buffer (137 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4) using Float-A-Lyzer (Serva, Heilderberg, Germany).
Affinity-purified protein was concentrated to 1.5 mg/mL by centrifugation over a 30-kDa cut-off
membrane (Amicon Ultra Centrifugal Filters, Merck Millipore, Darmstadt, Germany). A 0.5 mL sample
was loaded onto a Superdex 200 10/300 column (GE Healthcare, Little Chalfont, UK), equilibrated,
and eluted with a buffer containing 150 mM NaCl, 20 mM Tris-HCl, 2% (v/v) glycerol pH 7.8 with
a constant flow rate of 0.5 mL/min.
2.3. Protein Analysis Assays
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed according
to the method of Laemmli [24] using a 12% polyacrylamide gel or precast Tris-HCl PAGE gels (4%–20%,
gradient polyacrylamide gels, Bio-Rad), after heating the protein samples at 95 ◦C for 5 min. To evaluate
enzyme susceptibility to SDS and proteolysis, the samples of 30 µL containing 250 µg/mL depoKP36 in
the buffer (50 mM Na2HPO4, pH 7.0) containing 1% SDS (Bio-Rad) or 1% trypsin (Gibco BRL, Paisley,
UK) were incubated for 10 min at room temperature (RT) or 100 ◦C and at 37 ◦C for 1 h, respectively.
Further, the protein samples were mixed with Laemmli buffer (Bio-Rad), and analyzed in SDS-PAGE
as heated and unheated samples. For native PAGE, TGX precast gels (Bio-Rad), and running buffer
(25 mM Tris, 192 mM glycine, pH 8.3) were used. Sample buffer (62.5 mM Tris-HCl, 25% glycerol, 1%
bromophenol blue, pH 6.8) was mixed with a protein sample (1:1 v/v) and loaded without heating.
Molecular weight (MW) standards (10–250 kDa or 6.5–212 kDa) were used (Bio-Rad). The protein
bands were visualized by Coomassie brilliant blue R-250 (Bio-Rad) staining.
For zymogram assays, samples were boiled for 5 min before applying them to a 12% SDS-PAGE
gel, which contained 45% (v/v) crude EPS from K. pneumoniae. After electrophoresis, the zymograms
were washed with MilliQ water at RT and transferred to a buffer (0.15 M NaH2PO4, 10 mM MgCl2,
and 0.1% (w/v) Triton X-100; pH 7.0) for 48 h at RT for in situ protein renaturation. Following this, gels
were rinsed with MilliQ water, stained with methylene blue (0.1% (v/v), 0.001% (w/v) KOH) for 12 h at
RT, and then destained with water until enzyme activity bands appeared.
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The protein concentration was measured fluorometrically (Qubit 2.0, Thermo Fisher Scientific) or
spectrophotometrically (NanoDrop 2000 Spectrophotometer, Thermo Fisher Scientific) using a molar
extinction coefficient of 94,240 cm−1·M−1 calculated by ProtParam program [25].
2.4. Extraction and Purification of Exopolysaccharide (EPS)
To extract and purify EPS, a crude EPS fraction was prepared from supernatants of five-day
K. pneumoniae 486 cultures, according to the method of Bales et al. [26]. Briefly, 200 mL of TSB was
inoculated with 20 mL of an overnight culture of K. pneumoniae and incubated at 37 ◦C without
agitation for 5 days. Following the addition of 60 µL formaldehyde (36.5% solution) to each 10 mL of
culture for 1 h and then 1 M NaOH for 3 h at RT, with agitation, the secreted EPS was separated from
bacterial cells by centrifugation (16,800× g, 1 h, 4 ◦C). The proteins and nucleic acids were precipitated
by adding of trichloroacetic acid (TCA; 20% w/v) and subsequently centrifuging the solution (16,000× g,
1 h, 4 ◦C). The pellet was discarded and EPS remaining in the supernatants was precipitated away
from lipids by adding 1.5 volumes of 96% cold ethanol at −20 ◦C for 24 h. The precipitate was
collected by centrifugation (16,800× g, 1 h, 4 ◦C) and resuspended in MilliQ water. The crude EPS was
dialyzed against an excess of MilliQ water for 24 h at 4 ◦C using a 12–14 kDa molecular weight cut-off
(MWCO) membrane (Serva, Heidelberg, Germany) to remove low molecular weight impurities, and
the remaining retentate was lyophilized overnight. Next, the lyophilized powder was resuspended in
5–10 mL of water to a final concentration of 4 mg/mL.
2.5. Functional Assays
To visualize the enzyme activity, identifying the sensitivity of Klebsiella strains and comparing it
to phage-mediated lysis, spot assay was used. For this purpose, log-phase bacteria were transferred
directly onto TSA plates. After drying, both 10 µL of serially diluted recombinant enzyme or 10 µL the
phage suspension (108 PFU/mL) was spotted onto the bacterial lawn. After overnight incubation at
37 ◦C, plates were observed for formation of clear zones (halo) or lytic zones (plaque) surrounded by a
halo, respectively. For determination of bacterial count both in the halo zone and bacterial lawn, at
least two equal square agar blocks (5 mm × 5 mm) were cut out from each zone from three different
plates. Each block was suspended in 1 mL of PBS and vortexed. The number of bacteria was counted
after plating a dilution series of the supernatant. Bacterial cell viability after depoKP36 treatment was
also evaluated. Briefly, the log-phase bacteria (~2 × 108 CFU/mL) were incubated with the enzyme
(final concentration 280 µg/mL) for 2 h at 37 ◦C. The number of viable bacteria were determined at the
beginning and, afterwards, exposed to enzyme by serial dilution in PBS followed by overnight growth
at 37 ◦C on TSA plates.
The activity of depoKP36 at various pH levels (ranging from 3.0 to 9.0) and at various temperatures
(ranging from 20–80 ◦C) was assessed by measuring the decrease in turbidity according to the method
reported by Belleman et al. [27] with some modifications. Briefly, aqueous EPS solution extracted from
K. pneumoniae 486 (4 mg/mL), was dissolved in an appropriate buffer to final concentration 0.5 mg/mL.
The enzyme reaction was initiated by adding 115 µL of enzyme to 996 µL of substrate solution.
The mixture was incubated for 30 min at the desired buffer or temperature and then cooled. Remaining
polysaccharides were precipitated by adding cetylpyridinium chloride (CPC; Sigma-Aldrich, St. Louis,
MO, USA) to a final concentration of 5.1 mg/mL. After 10 min incubation at RT, the absorbance at
600 nm was measured (Asys UVM340, Biochrom Ltd., Cambourne, UK). Relative enzyme activity
was calculated and was expressed as percent reduction of turbidity compared with control without
enzyme. The influence of pH on enzyme activity was determined at 20 ◦C using the following buffers:
50 mM sodium acetate buffer (pH 3.0–5.0), 50 mM Na2HPO4 (pH 6.0–7.0), and 50 mM Tris-HCl buffer
(pH 8.0–9.0). To study the effect of temperature on enzyme activity, assays were performed in 50 mM
sodium acetate buffer (pH 5.0) in the range 20–80 ◦C. For the measurement of time evolution of enzyme
activity at different temperatures, depoKP36 was pre-incubated at the desired temperature in buffer at
pH 5.0 and samples were taken at regular time intervals (0, 10, 20, 30, 40, 50, and 60 min). After cooling
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the samples, residual activity was determined at 20 ◦C using the standard protocol described above.
Each experiment was performed in quadruplicate and repeated at least twice.
2.6. Galleria Mellonella Larvae Infection Model
Wax moth larvae (G. mellonella) were obtained from a culture of insects. Briefly, the larvae were
reared on a natural diet—honeybee nest debris at 30 ◦C in the dark. Prior to inoculation, the last instar
larvae were selected to be similar in size (approximately 250–350 mg) and were then maintained on
wood chips in darkness at 15 ◦C for 3–4 days. Bacteria from overnight culture were grown in TSB at
37 ◦C to log-phase for 2 h, harvested (5000× g, 20 min, 4 ◦C), washed with PBS and suspended in PBS to
an optical density at 600 nm of 1.0 corresponding to ~109 CFU/mL. Larvae were inoculated with 10 µL
of bacterial suspension containing 107 CFUs into the last pro-leg using insulin syringe with a 30-gauge
needle (NIO Lab, Nieborow, Poland). The anti-virulence effect of enzyme on K. pneumoniae 486 was
estimated by inoculated larvae with either bacteria pretreated with depoKP36 (final concentration,
280 µg/mL) for 2 h at 37 ◦C, or enzyme administered within 5 min after untreated bacterial infection.
Three control groups were used: uninfected larvae, larvae injected with PBS to monitor the killing
due to injection trauma, and larvae injected with depoKP36 to assess the toxicity of the enzyme.
After inoculation, caterpillars were kept at 37 ◦C in the dark for 72 h. The results were expressed as
the percentage survival rate estimated on the basis the touch-provoked motility and the appearance
of pigmentation at 24 h, 48 h, and 72 h post injection. For each option, at least three independent
experiments were performed (10 larvae per trial). Survival curves were plotted using the Kaplan-Meier
method, and the analysis in survival was performed by using the log-rank Mantel-Cox (GraphPad
Software, Inc., La Jolla, USA). A p-value of < 0.05 was considered to be statistically significant.
2.7. Antimicrobial Susceptibility Testing
K. pneumoniae strains (486 and 77) susceptibility to the antibiotics representing four different
classes: aminoglycosides (gentamicin sulfate; MP Biomedicals, Eschwege, Germany), fluoroquinolones
(ciprofloxacin; MP Biomedicals, Eschwege, Germany), tetracyclines (oksytetracycline; MP Biomedicals,
Eschwege, Germany), and chloramphenicol (Calbiochem, Darmstadt, Germany), was determined
by a broth microdilution technique according to Clinical and Laboratory Standards Institute (CLSI)
recommendations [28]. For quality control, K. pneumoniae ATCC 700603 was included in each set of tests.
The minimal inhibitory concentration (MIC) was determined as the lowest antibiotic concentration at
which there is no visible growth.
To evaluate the activity of depoKP36 combined with antibiotics against K. pneumoniae strains, the
checkerboard broth microdilution method was used. Two-fold serial dilutions of the antibiotic, in a
range between 2 MIC and 1/4 MIC, and two-fold serial dilutions of the enzyme (final concentrations
from 125 µg/mL to 7.81 µg/mL) were prepared for every option tested and 100 µL aliquots of
each component was added into the wells of the sterile 96-well microtiter plate (VWR International,
Darmstadt, Germany), along the ordinary and abscissa, respectively. Then each well was inoculated
with 10 µL of a bacterial inoculum of 5 × 105 CFU/mL, and the plates were incubated at 37 ◦C for 18 h.
The MIC was determined as the lowest concentrations of antibiotic in combination with the enzyme
giving complete inhibition of visible growth.
2.8. Light Scattering Experiments
Purified, not aggregated depoKP36 was analyzed by size-exclusion chromatography (SEC)
coupled to a miniDAWN TREOS multi-angle static light scattering (MALS) detector (Wyatt Instrument
Technology Corp., Santa Barbara, CA, USA) and an OptilabTM rEX (Wyatt Instrument Technology
Corp.). The protein sample of 2 mg was loaded on a S200 10/30 column, previously equilibrated in
200 mM NaCl, 25 mM HEPES, 5% glycerol, pH 7.8. A constant flow rate of 0.5 mL/min was applied.
The online measurement of the intensity of the Rayleigh scattering as a function of the angle as well as
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the differential refractive index of the eluting peak in SEC was used to determine the average MW of
eluted protein using Astra 5.3.4.14 (Wyatt Instrument Technology Corp.) software.
2.9. Circular Dichroism (CD) Studies
Circular dichroism (CD) spectroscopy and thermal melting curves were recorded on a Jasco
J-810 spectropolarimeter fitted with a single cell Peltier temperature controller (Model PTC-423S). CD
measurements were carried out at 20 ◦C in a 0.1 cm optical path length cell with protein concentration
of 0.2 mg/mL in 20 mM sodium acetate buffer (pH 6.0) containing 150 mM NaCl. Each spectrum was
scanned from 260 nm to 190 nm with an integration time of 3 s at each wavelength. All spectra were
averaged from three scans and baseline-corrected using a blank consisting of sodium acetate buffer
(20 mM, pH 6.0). The molar ellipticity per mean residue, [
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3. Results
3.1. Identification of Phage KP36 gp50 as a Putative EPS Depolymerase
The ability of bacteriophages to enzymatically degrade bacterial polysaccharides is an effective
strategy allowing the virions to deliver their genome across the bacterial envelope to the cell cytoplasm,
where their genetic information is expressed and replicated. While studying the phage KP36,
we noticed the appearance of hazy, expanding halo zones surrounding plaques with a small clear
center formed by it on a bacterial lawn [21]. This observation indicated that phage KP36 may produce
a virion-associated polysaccharide-degrading enzyme.
Protein Blast (BlastP) analysis of the gp50 gene product (putative tailspike protein) showed
high sequence identity of the N-terminal region to the tail fiber protein of Klebsiella phage Sushi and
hypothetical phage proteins of Klebsiella phage 1513, Enterobacter phage F20 and Klebsiella phage KLPN1
(Figure 1a) [29]. Moreover, the C-terminal region has significant sequence identity to Klebsiella phage
KP34 gp57. Amino acid sequence also evidenced a fragment exhibiting similarity to the pectate lyase
superfamily (residues 263–330). Of note, none of the aforementioned phage proteins has yet been
characterized in vitro.
Whereas no significant sequence similarity with structurally determined proteins was found using
BlastP, sequence comparisons using consensus sequence methods by HHPred identified two moderate
homologs in the Protein Data Bank (PDB) database [30]. Those included a pre-neck appendage protein
from Bacillus phage phi29 (pdb code 3gq8) and polygalacturonase II from Aspergillus niger (pdb code
1bhe), (Figure 1b). Both proteins contain high β-helical structure. Consistently, secondary structure
predictions using PSIPRED [31] indicate that gp50 of phage KP36 possesses a dominant amount of
beta-structure (53%), similar to other identified polysaccharide binding enzymes of viral or microbial
origins [32,33].
All of this information suggested that the product of gene gp50 is a probable polysaccharide
depolymerase involved in the phage attack against its host bacterium. Therefore, we cloned,
expressed, and purified the full-length protein (883 amino acids) with predicted molecular mass
of 93.4 kDa and a pI of 5.0, here designated as depoKP36, to gather understanding on its functional
and structural properties.
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Enzymatic activity of depoKP36 was further tested on clinical K. pneumoniae strains panel using 
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isolates corresponded  to  the K63  reference strain,  the others  represented  the  three other capsular 
Figure 1. Bioinformatic analysis of Klebsiella phage KP36. (a) BlastP analysis in non-redundant sequence
database; (b) HHPred analysis in Protein Data Bank (PDB).
3.2. Recombinant depolymerase enzyme encoded by Klebsiella phage KP36 (depoKP36) Degrades Bacterial EPS
and Shows a Narrow Spectrum Activity Against Specific K. pneumoniae Strains
The recombinant depoKP36 was purified in the two-step strategy coupling nickel affinity and
gel filtration procedures (Figure 2). The size-exclusion chromatography profile indicated that the
purified protein was predominantly homogeneous, with only a small proportion in an aggregated
state. Only fractions involving the main peak corresponding non-aggregated protein were pooled
and subjected to further studies. The purified depoKP36 migrated as a single band on SDS-PAGE
corresponding to an approximately 93.4 kDa protein.
The activity of depoKP36 was tested on K. pneumoniae 486 lawn by spot assay with halo
zone detection using enzyme dilutions ranging from 50 µg/mL to 3.1 µg/mL (Figure 3a).
The capsular staining of bacteria present in and outside of zone indicated the degradation of
capsular material. The presence of almost equal amounts of viable cells in samples from both areas
(2.9 × 109 ± 3.0 × 108 CFU/mL and 3.6 × 109 ± 3.5 × 108 CFU/mL, respectively) suggested the lack
of affected cell viability.
To confirm that depoKP36 acts as polysaccharide depolymerase, we subsequently extracted and
purified EPS from supernatants of host culture and applied zymography analysis to visualize its
enzymatic activity. As shown in Figure 3b, a single band of clearing at ~94 kDa, which corresponds to
the size of the complete depoKP36 protein, was observed on zymograms. The same band was seen
after phage KP36 application.
Enzymatic activity of depoKP36 was further tested on clinical K. pneumoniae strains panel using
spot test. The phage KP36 was included as a positive control. Among the 11 strains tested, eight (73%)
isolates corresponded to the K63 reference strain, the others represented the three other capsular types,
namely K3, K10 and K20. Only K63 type bacteria proved to be susceptible to CPS degradation by both
the protein and phage, whereas none of the other aforementioned capsular types were as sensitive.
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depoKP36 on host strain. Phosphate‐buffered saline (PBS) was used as a control; (b) Zymography. 
Protein samples run on a 12% standard Laemmli SDS‐PAGE gel containing crude exopolysaccharide 
(EPS) as a substrate. Zymograms were stained with methylene blue. Lane MW: MW markers; lane 1: 
recombinant depoKP36 (2.5 μg/lane); lane 2: phage KP36 (109 PFU/lane). 
3.3. Anti‐Virulence Efficacy of depoKP36 in the G. mellonella Infection Model 
Given the therapeutic efficacy of depolymerase in murine model of K. pneumoniae infections [17] 
and the capsule necessity for K. pneumoniae virulence in G. mellonella larvae [34], we evaluated the 
virulence of depoKP36‐treated Klebsiella strain as well as the efficacy of treatment with this enzyme 
in vivo using  the  insect model. Without  the  treatment, 100% of  the  larvae died within 24 h after 
inoculation of 107 cells of K. pneumoniae 486 (Figure 4). In contrast, a single dose of enzyme given 
Figure 2. Expression and purification of the depolymerase enzyme encoded by Klebsiella phage KP36
(depoKP36); (a) Ni-NTA His·Bind®Resins affinity column purification. Protein samples run on a
reducing 12% gel. Lane MW: molecular weight (MW) markers; lane 1: lysate of induced E. coli
BL21 pEXP-5-CT/TOPO®-depoKP36 cells; lane 2: column wash with buffer containing 10 mM
imidazole; lane 3: eluted proteins; (b) Gel filtration chromatogram; (c) Eluted protein after gel filtration
chromatography. Protein samples were separated on 4–20% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) gel. Lane MW: MW markers; lane 1: aggregate protein; lanes 2, 3, 4, 5:
non-aggregate protein fractions. Samples were stained using Coomassie brilliant blue R-250. The arrow
indicates protein of interest, depoKP36; SEC: size-exclusion chromatography.
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in vivo using  the  insect model. Without  the  treatment, 100% of  the  larvae died within 24 h after 
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3.3. Anti-Virulence Efficacy of depoKP36 in the G. mellonella Infection odel
Given the therapeutic efficacy of depolymerase in murine model of K. pneumoniae infections [17]
and the capsule necessity for K. pneumoniae virulence in G. mellonella larvae [34], we evaluated the
virulence of depoKP36-treated Klebsiella strain as well as the efficacy of treatment with this enzyme
in vivo using the insect model. ithout the treatment, 100% of the larvae died within 24 h after
inoculation of 107 cells of K. pneumoniae 486 (Figure 4). In contrast, a single dose of enzyme given
within 5 min after bacteria injection as well as inoculation of bacteria pretreated with depoKP36
for 2 h, significantly inhibited K. pneumoniae-induced death in a time-dependent manner (p < 0.003).
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At 24 h and 48 h post application of depoKP36, the survival rate of Galleria increased by up to 40%
and 30%, respectively. At 72 h another 10% of the remaining survivors were dead. In turn, bacteria
treated with depoKP36 prior to inoculation killed only 23% of the larvae at 24 h compared to 53%
and 57% mortality at 48 h and 72 h, respectively. No mortality of larvae was observed in the controls,
upon injection of PBS buffer or depoKP36. No differences in the number of viable bacteria were
detected before (2.58 × 108 CFU/mL ± 5.12 × 107 CFU/mL) and 2 h after exposure to depoKP36
(2.8 × 108 CFU/mL ± 4.07 × 107 CFU/mL).
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Figure  4.  Inhibition  of K.  pneumoniae–induced mortality  by depoKP36 using G. mellonella model. 
Larvae (n = 30) were injected with either bacteria (107 CFUs/per larvae), enzyme (final concentration, 
280  μg/mL)  administered within  5 min  after untreated bacteria  inoculation, or depoKP36‐treated 
bacteria, and monitored for mortality. The experiments were controlled by observation of uninfected 
larvae, PBS‐injected larvae and larvae receiving the enzyme only. Survival for each control group was 
100%, so for simplicity, these groups were not included in the figure. Survival curves were plotted 
using the Kaplan‐Meier method, and differences in survival were calculated by using the log‐rank 
test (GraphPad); * p < 0.003 (considered to be statistically significant); Results are the means of at least 
three independent experiments. 
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Figure 4. Inhibition of K. pneumoniae–induced mortality by depoKP36 using G. mellonella model.
Larvae (n = 30) were injected with either bacteria (107 CFUs/per larvae), enzyme (final concentration,
280 µg/mL) administered within 5 min after untreated bacteria inoculation, or depoKP36-treated
bacteria, and monitored for mortality. The experiments were controlled by observation of uninfected
larvae, PBS-injected larvae and larvae receiving the enzyme only. Survival for each control group was
100%, so for simplicity, these groups were not included in the figure. Survival curves were plotted
using the Kaplan-Meier method, and differences in survival were calculated by using the log-rank test
(GraphPad); * p < 0.003 (considered to be statistically significant); Results are the means of at least three
independent experiments.
3.4. DepoKP36 Do Not Affect the Action of Antibiotics Against K. pneumoniae Strains
To gain further insight of the therapeutic potential of depoKP36, we evaluated the activity of the
enzyme in combination with four classes of antibiotics against two K. pneumoniae strains (486 and 77)
representing the K63 capsular type. The MIC values have not changed for each particular antibiotic
after depoKP36 application indicating that depolymerase did not alter the potency of any antibiotics
tested. The ciprofloxacin, oxytetracycline, and chloramphenicol MICs for both Klebsiella strains were
0.125–0.25 µg/mL, 1 µg/mL, and 2µg/mL, respectively, whereas the MIC of gentamicin was 0.5 µg/mL
for strain 486 and >32 µg/mL for strain 77.
3.5. DepoKP36 Remains Stable at Moderately Acidic Conditions and Is Mesophilic
A quantitative measure of the enzymatic activity of depoKP36 in a range of pH and temperatures
was obtained by monitoring the decrease of turbidity of aqueous solutions of EPS extracted from
K. pneumoniae 486 (0.5 mg/mL) following the enzyme action (Figure 5). Relative enzyme activity was
expressed as percent reduction of turbidity compared with the control without enzy e. The activity
range of depoKP36 on its natural substrate as a function of either pH or temperature was determined
after 30 min incubation in the proper buffer. As a result, we observed that depoKP36 re ains
active over a pH range, from 4.0 to 7.0, with relative activities ranging from 97.1% ± 1.02% to
97.8% ± 0.57%. The activity diminished substantially as the pH was lowered below 4.0 or raised
above 7.0, to 54.6% ± 2.81% and 14.0% ± 14.17% of initial activity, respectively. Based on these results,
depoKP36 can be considered an acidically stable enzyme. Therefore, the enzyme activity at pH 5.0 in
the temperature range from 20 ◦C to 80 ◦C was investigated. Optimal activity of the enzyme was found
at temperatures ranging from 20 ◦C to 37 ◦C, which probably reflect adaptation to the physiological
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environment of the K. pneumoniae bacteria. Non-significant reduction, to 95% of the initial activity, was
observed at 45 ◦C, whereas heat treatments at 56 ◦C and 62 ◦C lowered the enzyme relative activity to
70%. When heated at 70 ◦C, the enzymatic activity of depoKP36 fell below 60% of the initial activity.
At higher temperatures, depoKP36 was completely inactivated.
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To gain further insight into the effect of temperature on enzyme activity in solution, depoKP36
was preincubated without the substrate at different temperatures (from 37 ◦C to 65 ◦C) in a buffer at
pH 5.0, and the samples were drawn at various time points. The incubation at 37 ◦C has no effect on
relative turbidity whereas time evolution of turbidity measurements at 45 ◦C shows a small decrease
(77.6% ± 9.0%) after 60 min of incubation. The decrease of turbidity becomes drastic at 56 ◦C and
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65 ◦C, with complete suppression after 30 and 10 min, respectively. Altogether, these data show that
depoKP36 is active in a wide range of temperatures, from 20 ◦C to 45 ◦C.
3.6. Structural Characterization of depoKP36 in Solution
A search of the PDB database identifies polygalacturonase II from Aspergillus niger (seq id 13%
on residues 206–383) as the protein of known structure most similar to depoKP36. Due to this scarce
available structural information, we carried out structural studies in solution using CD and light
scattering experiments. CD spectra showed that depoKP36 adopts a well-folded conformation, with
a negative dichroic minimum between 210 and 220 nm and a positive dichroic maximum between
195 and 200 nm, characteristic of a protein with high β-sheet content (Figure 6a). To investigate the
heat-induced changes in the protein secondary structure, thermal unfolding curves were achieved
by following the CD signal at 214 nm as a function of temperature. Thermal unfolding curves show
a sigmoidal transition with melting temperature (Tm) = 65 ◦C (Figure 6b).
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Figure 6. (a) Circular dichroism (CD) spectrum of depoKP36 (0.2 mg/mL) in sodium acetate 20 mM,
pH 6.0; (b) Thermal denaturation curve measured at 214 nm. The midpoint of the curve was used to
calculate the melting transition temperatures (Tm) for protein.
Analytical SEC, coupled with MALS (SEC-MALS), was carried out to investigate the
oligomerization state of depoKP36 in solution. The online measurement of the intensity of the Rayleigh
scattering as a function of the angle as well as the differential refractive index of the eluting peak in
SEC was used to determine the MW (Figure 7a). This analysis produced an MW of 255 kDa, which
corresponds to a trimeric organization of the protein in solution. This MW was also confirmed by
native gel electrophoresis (Figure 7b).
Furthermore, to analyze the structural integrity of depoKP36 in the presence of both anionic
detergent and protease, the electrophoretic mobility of the enzyme was studied. As shown in Figure 8,
depoKP36 migrated as a monomer at 94 kDa during SDS-PAGE regardless of SDS-treated sample
heating, which indicates that SDS is sufficient for enzyme denaturation. In turn, the lack of a
visible band reflecting this protein on the gel after trypsin treatment suggests its vulnerability to
proteolytic cleavage.
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4. Discussion
Given the crucial role of the CPS in the pathogenesis of Klebsiella infections, it is not surprising that
the pote tial of phage-enc ded protei s with polysaccharide depolymerization activity to generate
“capsule-stripped” strains has been the subject of extensive studies [17,20,35–38]. Such enzymes can
sensitize the bacterial cells maki g them more susceptible to a component of the host’s immune
system as well as to antimicrobials [39,40]. The other advantages of these roteins are t e low
incidence of resistance gener tion and l ck of side eff cts on normal microbiota [40,41]. For these
reasons, a novel depolymerase enzyme, encoded by Klebsiella phage KP36 from the Siphoviridae family,
h s been identified and characterized in this study to evaluate its effectiveness against encapsulated
bacteria in vitro and in vivo. As other r combinant enzymes that cleav Klebsiella CPS reported so
far, were encoded by Podoviridae and Myoviridae phages [8,20,36,38,42], d poKP36 constitutes the first
recombinant depolymerase obtained from siphovirus specific gainst Klebsiella.
NCBI BLAST results reveal d that depoKP36 shares about 67–88% amino-acid identities in
the -terminal region with oth r putative tail fiber proteins from Klebsiella and Enterobacter phag s,
belonging to the same family of Siphoviridae and m r specifically the “KP36likevirus” genus [22,43].
Such hi h homology within mor logically si ilar phages may indicate th pre ence in this part
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of a domain anchoring the tail fiber to the phage particle. In turn, the exhibition of a C-terminal
sequence similarity to the gp57 of Klebsiella phage KP34 from Podoviridae, and the identification of
common host spectrum for both phages [21,44] suggests that it is the region responsible for recognizing
polysaccharides and binding to the host cell receptor. Also, a pectate lyase domain fragment, found in
the sequence alignment, indicates the involvement of depoKP36 in the modification or cleavage of
glycoside bonds in the capsular polysaccharide. Previously, this domain has been reported in other
phage tail spike proteins targeting and degrading CPS, like K5 lyase of coliphage K5A [45] and Tsp2 of
phage ΦSH19 [46].
Our study proved that depoKP36 is able to digest the capsule from the surface of all isolates with
a wzi sequence corresponding to the K63 reference strain. Also, the zymography confirmed that this
enzyme efficiently degrades purified EPS from Klebsiella serotype 63. Notably, this polysaccharide
structure with repeating units of [→3)-α-D-Galp-(1→3)-α-D-GalpA-(1→3)-α-L-Fucp (1→] [47] is
identical to that of E. coli serotype K42 capsular polysaccharide [48], a finding which could potentially
extend the spectrum of bacteria susceptible to this protein. Furthermore, modifications of depolymerase
could further expand its bacterial spectrum [49]. Indeed, it has been shown that even a single amino
acid substitution in the active site of phage HK620 tailspike protein results in an increase of binding
affinity of up to three orders of magnitude [50] and that, upon mutations, the enzyme can gain the
ability to recognize other bacterial surface receptors [51].
Together with the evaluation of the ability of depoKP36 to degrade capsular polysaccharides
in vitro, we investigated its effect in vivo using the G. mellonella model. The innate immune response
of insects in many aspects reflects the defensive mechanisms against Klebsiella-triggered pneumonia
in animals [34]. In our study, the results obtained on the wax moth larvae model confirm the idea of
utilization of these phage-encode proteins as anti-virulent agents. The increased larval survival rates
following the application of the enzyme or bacteria treated with it prior to inoculation suggests the
decrease in bacterial virulence as the consequence of the loss of capsule layer as the major Klebsiella
pathogenicity factor.
Given the improved gentamicin efficacy against K. pneumoniae serotype K2 after using the
bacterial depolymerase [40], we further evaluated the activity of depoKP36 in combination with
four classes of antibiotics. Unlike the in vivo studies involving the bacterial enzyme [40], our in vitro
experiments have not revealed the ability of phage-derived depolymerase to potentiate the efficacy of
aminoglycoside antibiotic against K. pneumoniae. Also, the efficacy of ciprofloxacin (fluorochinolones),
oksytetracycline (tetracyclines), and chloramphenicol did not change after administration of depoKP36.
Nevertheless, besides no improvement of antibiotic activity it is worth mentioning that depolymerase
treatment does not disturb drug action. Thus, reducing other virulence factors responsible for the
susceptibility to immune response, the final result of depolymerase application may lead to the
improvement of the drug/enzyme combined therapy.
Our results showed that depoKP36 displays moderate acidic-stability with the optimum pH in the
range from 4.0 to 7.0, similar to the depolymerase from Klebsiella phage P13 [38]. This pH-dependence
of enzyme activity agrees well with the ability of K. pneumoniae to infect the urinary tracts, as the pH of
urine ranges from 6.5 to 7.0. From this perspective, such enzymes could be interesting candidates for
anti-virulence agents in a hurdle approach for catheter preservation, in addition to other antimicrobial
additives. On the contrary, the enzymes from phages specific to K. pneumoniae 390 and B5055 were
found to be stable in a pH range shifted toward more alkaline conditions, from 6.0 to 9.0 or 10.0,
respectively [14,36]. The activity of depoKP36 was optimal in the range from 20 ◦C to 37 ◦C, what
ensures the best efficacy during the therapy, as well as anti-virulent/anti-biofilm preservation agent
when applied as catheter additive. The trimeric structure of depoKP36, as reported for other tailspike
proteins, including those from phages: P22 [52], Sf6 [53], HK620 [54], phi 29 [55], Det7 [56], and
9NA [57], provides a high stability at different pH and temperature conditions, but most importantly
it increases the avidity of protein-carbohydrate interactions [49]. Unlike most of the described viral
fibers, the depoKP36 remains susceptible to SDS-induced denaturation and proteolytic cleavage [33,58].
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In proteins with a high content of β-structure, denaturation in the presence of SDS increases the amount
of α-helix structure [59]. This favors the formation of a “bead-on-a-string” structure, in which the SDS
micelles bind to proteins, stabilizing it in this way [60]. This also suggests that SDS-conformational
changes might facilitate access of the active site of the enzyme to the substrate.
In conclusion, the identification of a novel depolymerase and the characterization of its catalytic
and structural features add insights to the understanding of the mode of action of phage-derived
enzymes able to digest bacterial polysaccharides. Altogether, our findings demonstrate that depoKP36
is the enzyme responsible for the ability of KP36 phage to degrade the bacterial capsule, making
bacteria less pathogenic and more easy to eradicate by immune response mechanisms. What is more,
the bacterial capsule serves as the effective adherence element conditioning the formation of biofilm
structure on living and artificial surfaces. Therefore, our results provide grounds to use depoKP36 as
a phage-based anti-biofilm tool. Indeed, the observed efficacy, stability, and specificity of depoKP36
makes it suitable for various purposes, including the monitoring of biofilm formation and bacterial
detection, coating of medical tools and devices, and glycans analyses.
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